摘要
目的明确^125放射性粒子肿瘤内永久植入治疗Ⅳ期胰腺癌患者的意义。方法回顾分析在CT、超声引导下^125放射性粒子治疗18例Ⅳ期胰腺癌临床资料，观察疼痛缓解情况及平均生存期，并与国内大宗统计数据结果比较。结果疼痛缓解率70．6％（12／17），开始缓解平均时间2．9d；术后生存期2．5～11．5个月，平均5．2个月，较中国抗癌协会胰腺癌专业委员会统计的Ⅳ期胰腺癌患者生存期（3．0个月）明显延长。结论^125放射性粒子治疗可有效提高Ⅳ期胰腺癌患者的生活和生存质量。
Objective Subjective to identify the significance of interstitial implantation of ^125I seeds in stage Ⅳ pancreatic cancer patients. Methods Retrospectively analysis the clinical datum of 18 cases of stage Ⅳ pancreatic cancer patients treated with the ^125I seeds implantation, and observe the pain relief rate and the average survival period, then compare with the bulk of domestic statistical datum. Results The rate of easement of pain was 70.6% （12/17） , and the mean time begin to relieve was 2.9 days . The life span after the operation was between 2.5 and 11.5 months , and 5.2 months on average,which is longer conspicuously than the statistics of the past. Conclusions The methods of interstitial implantation of ^125I seeds can upgrade the quality of the life and living efficiently of stage Ⅳ pancreatic cancer patients.
出处
《中华内分泌外科杂志》
CAS
2009年第2期95-96,119,共3页
Chinese Journal of Endocrine Surgery
基金
吉林省科委基金项目（基金编号200505159）
吉林省科技发展计划项目（基金编号20070153）
